Reiner Bruce I
Department of Diagnostic Imaging, Baltimore VA Medical Center, Baltimore, Maryland 21201, USA.
J Am Coll Radiol. 2009 Aug;6(8):558-61. doi: 10.1016/j.jacr.2009.04.007.
An integral part of cost-benefit analysis within medicine is the comparative assessment of the clinical gains introduced by a service or application compared with the patient costs, which can be measured in economic or clinical terms. When analyzing medical imaging, a number of factors must be included, the most important of which include issues pertaining to patient safety, image quality, and clinical outcomes. Although ionizing radiation has long been recognized as a potential carcinogen capable of introducing harm to patients, the long-term derived benefits have been accepted because of the diagnostic and therapeutic benefits derived from its use. With the increased utilization of high-dose ionizing radiation examinations (such as multidetector computed tomography), it is essential that the medical community create data-driven methodologies to quantify risk in objective terms, develop community-wide radiation standards and "best practice" guidelines (evidence-based medicine), develop new technologies and applications to proactively minimize radiation dose while maintaining quality, and create accountability measures for all pertinent stakeholders.
医学中成本效益分析的一个重要组成部分是,将某项服务或应用带来的临床收益与患者成本进行比较评估,患者成本可以从经济或临床角度来衡量。在分析医学成像时,必须考虑多个因素,其中最重要的因素包括与患者安全、图像质量和临床结果相关的问题。虽然电离辐射长期以来一直被认为是一种能够对患者造成伤害的潜在致癌物,但由于其使用带来的诊断和治疗益处,其长期衍生益处已被接受。随着高剂量电离辐射检查(如多排螺旋计算机断层扫描)的使用增加,医学界必须创建以数据为驱动的方法,以客观的方式量化风险,制定全社区的辐射标准和“最佳实践”指南(循证医学),开发新技术和应用,在保持质量的同时主动将辐射剂量降至最低,并为所有相关利益攸关方制定问责措施。